XML 57 R33.htm IDEA: XBRL DOCUMENT
v3.26.1

Disclosure on Individual Items of the Consolidated Financial Statements (Details) |  |  |  | 12 Months Ended |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Sep. 30, 2025 EUR (€) | Aug. 20, 2025 shares | Dec. 28, 2023 EUR (€) shares | Dec. 28, 2023 USD ($) | Dec. 31, 2025 EUR (€) shares | Dec. 31, 2025 USD ($) $ / shares shares | Dec. 31, 2024 EUR (€) shares | Dec. 31, 2024 USD ($) $ / shares shares | Dec. 31, 2023 EUR (€) shares | Dec. 31, 2023 USD ($) shares | Dec. 31, 2025 USD ($) $ / shares shares | Apr. 30, 2025 shares | Dec. 31, 2024 USD ($) $ / shares shares | Dec. 28, 2023 USD ($) $ / shares shares | Dec. 31, 2022 EUR (€) | Jan. 26, 2021 shares
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue from contracts with customers |  |  |  |  | € 31,559,000 |  | € 110,013,000 |  | € 107,384,000 |  |  |  |  |  |  |
Write-downs of inventories |  |  |  |  | 27,188,000 |  | 13,991,000 |  |  |  |  |  |  |  |  |
Share-based payments |  |  |  |  | 2,655,000 |  | 3,866,000 |  | 1,451,000 |  |  |  |  |  |  |
Amortization of capitalized development costs |  |  |  |  | 7,887,000 |  | 4,111,000 |  | 2,463,000 |  |  |  |  |  |  |
Government grants amount |  |  |  |  | € 0 |  | 3,082,000 |  | 692,000 |  |  |  |  |  |  |
Carrying amount of asset |  |  |  |  |  |  | 692,000 |  | 692,000 |  |  |  |  |  |  |
Finance expense from remeasurement of warrant liabilities |  |  |  |  |  |  | 62,170,000 |  | 10,859,000 |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  |  |  | 60,516,474 |  |  |  |  |  | 60,516,474 | 1,116,072 |  |  |  |
Par value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  | $ 15.51 |  |  |
Interest expense | € 500,000 |  |  |  | € 20,795,000 |  | € 10,919,000 | $ 0 |  | $ 0 |  |  |  |  |  |
Effective tax rate |  |  |  |  |  |  | 29.48% | 29.48% |  |  |  |  |  |  |  |
Corporate tax rate |  |  |  |  |  |  | 15.00% | 15.00% |  |  |  |  |  |  |  |
solidarity surcharge percentage |  |  |  |  |  |  | 5.50% | 5.50% |  |  |  |  |  |  |  |
Trade tax |  |  |  |  |  |  | 13.65% | 13.65% |  |  |  |  |  |  |  |
Deferred Taxes Amount (in Dollars) | $ |  |  |  |  |  | $ 134 |  |  |  |  |  |  |  |  |  |
Recognized Deferred Taxes |  |  |  |  | 3,310,000 |  | € 643,000 |  |  |  |  |  |  |  |  |
Loss attributable to the shareholders |  |  |  |  | € (55,190,000) |  | € (97,958,000) |  | € (55,081,000) |  |  |  |  |  |  |
Weighted average basic (in Shares) | shares |  |  |  |  | 56,394,000 | 56,394,000 | 51,224,000 | 51,224,000 | 48,919,000 | 48,919,000 |  |  |  |  |  |
Weighted average diluted (in Shares) | shares |  |  |  |  | 56,394,000 | 56,394,000 | 51,224,000 | 51,224,000 | 48,919,000 | 48,919,000 |  |  |  |  |  |
Remaining useful life |  |  |  |  | 3 years | 3 years |  |  |  |  |  |  |  |  |  |
Additional Amortization Amount |  |  |  |  | € 3,598 |  |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  |  |  |  | 10.00% |  |  |  |  |  | 10.00% |  |  |
Rental income, operating |  |  |  |  | 137,000 |  | € 137,000 |  |  |  |  |  |  |  |  |
Cash deposit |  |  |  |  | 37,000 |  | 37,000 |  |  |  |  |  |  |  |  |
Write-downs of inventories |  |  |  |  | 13,198 |  | 689,000 |  | € 8,093,000 |  |  |  |  |  |  |
VAT receivable |  |  |  |  | 551,000 |  |  |  |  |  |  |  |  |  |  |
salaries and wages amount |  |  |  |  | 160,000 |  |  |  |  |  |  |  |  |  |  |
Deferred day one loss |  |  |  |  | € 933,000 |  | 13,447,000 |  |  |  |  |  |  |  |  |
Constant maturity US treasury rates |  |  |  |  | 1 year 11 months 23 days | 1 year 11 months 23 days |  |  |  |  |  |  |  |  |  |
Percentage of dividend yield |  |  |  |  | 0.00% | 0.00% |  |  |  |  |  |  |  |  |  |
Percentage of drawdown probability |  |  |  |  | 5.00% | 5.00% |  |  |  |  |  |  |  |  |  |
Other accrued |  |  |  |  | € 537,000 |  | 624,000 |  |  |  |  |  |  |  |  |
Cash at banks includes restricted cash |  |  |  |  |  |  | 644,000 |  |  |  |  |  |  |  |  |
Issued share capital |  |  |  |  | 5,000 |  | € 5,000 |  | 4,000 |  |  |  |  |  | € 5,000 |
Exercise price of warrants (in Dollars per share) | $ / shares |  |  |  |  |  |  |  | $ 7 |  |  |  |  |  |  |  |
Exercise price of warrants increase (in Dollars per share) | $ / shares |  |  |  |  |  |  |  | $ 8 |  |  |  |  |  |  |  |
Increase equity |  |  | € 7,009,000 | $ 7,802,000 |  |  |  |  |  |  |  |  |  |  |  |
Warrants liabilities |  |  | 1,989,000 |  |  |  |  |  |  |  |  |  |  | $ 2,198,000 |  |
Transaction costs |  |  | 268,000 | $ 283,000 |  |  |  |  |  |  |  |  |  |  |  |
Public warrants (in Shares) | shares |  |  |  |  |  |  | 36,872 | 36,872 |  |  |  |  |  |  |  |
Capital reserves |  |  |  |  | 332,907,000 |  | € 245,298,000 |  | 225,007,000 |  |  |  |  |  |  |
Exercise of warrants |  |  |  |  | 26,950,000 |  | 9,260,000 |  |  |  |  |  |  |  |  |
Shareholder loans |  |  |  |  | 2,274,000 | $ 4,328,747 | € 1,067,000 |  |  |  |  |  |  |  |  |
Ordinary price per share |  |  |  |  | 390 |  |  |  |  |  | $ 0.0001 |  |  |  |  |
Increase in capital reserves |  |  |  |  | € 63,851 | $ 57,539 |  |  |  |  |  |  |  |  |  |
Convertible note agreement description |  |  |  |  | On May 01, 2025, ADSE secured financing through convertible note agreements with different insti-tutional lenders in a total principal amount of kUSD 53,763 (kEUR 47,398). The notes were issued with a discount of 7% and bear interest of 2% p. a. They can either be converted into equity or redeemed in cash over a period of three years until May 01, 2028. Together with the convertible notes, 1,116,072 warrants were issued resulting in a disagio of the notes in an amount of kEUR 9,000. Transaction costs are being discounted from the notes as well. Both are amortized together with the issue discount using the effective interest rate method. | On May 01, 2025, ADSE secured financing through convertible note agreements with different insti-tutional lenders in a total principal amount of kUSD 53,763 (kEUR 47,398). The notes were issued with a discount of 7% and bear interest of 2% p. a. They can either be converted into equity or redeemed in cash over a period of three years until May 01, 2028. Together with the convertible notes, 1,116,072 warrants were issued resulting in a disagio of the notes in an amount of kEUR 9,000. Transaction costs are being discounted from the notes as well. Both are amortized together with the issue discount using the effective interest rate method. |  |  |  |  |  |  |  |  |  |
Convertible notes settled description |  |  |  |  | Until that date, the lenders had converted a total principal amount of kUSD 29,170 (kEUR 25,162) as well as interest in the amount of kUSD 1,844 (kEUR 1,591) into equity resulting in a total increase of share capital of EUR 306 and an addition to the capital reserve of kEUR 26,753. The remaining outstanding principal and interest were settled in cash. | Until that date, the lenders had converted a total principal amount of kUSD 29,170 (kEUR 25,162) as well as interest in the amount of kUSD 1,844 (kEUR 1,591) into equity resulting in a total increase of share capital of EUR 306 and an addition to the capital reserve of kEUR 26,753. The remaining outstanding principal and interest were settled in cash. |  |  |  |  |  |  |  |  |  |
Warrant liabilities |  |  |  |  | € 43,550,000 |  |  |  |  |  |  |  |  |  |  |
Share price (in Dollars per share) | $ / shares |  |  |  |  |  | $ 18 |  |  |  |  |  |  |  |  |  |
Price per warrant (in Dollars per share) | $ / shares |  |  |  |  |  | $ 0.01 |  |  |  |  |  |  |  |  |  |
Fair market value price per shares (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 11.5 |  |  |  |  |
Warrants issued (in Shares) | shares |  |  |  |  |  |  | 7,300,003 |  | 3,216,667 |  |  |  | 7,300,003 |  |  |
Fair value of warrants |  |  |  |  |  |  | € 13,981,000 |  |  |  |  |  |  |  |  |
Remaining Outstanding Warrants (in Dollars) | $ |  |  |  |  |  | $ 1,680,000 |  |  |  |  |  |  |  |  |  |
Warrants exercise price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 16.88 |  |  |  |  |
Shares of Warrants (in Dollars) | $ |  |  |  |  |  | 161,290 |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars) | $ |  |  |  |  |  | $ 6.2 |  |  |  |  |  |  |  |  |  |
Aggregate fair value |  |  |  |  | 6,773,000 |  |  |  |  |  |  |  |  |  |  |
Fair value of warrants |  |  |  |  | 9,014,000 |  |  |  |  |  |  |  |  |  |  |
Loans and borrowings amount |  |  |  |  |  |  | 11,971,000 |  | € 5,006,000 |  |  |  |  |  |  |
Interest payable |  |  |  |  |  |  | € 1,363,000 |  | € 5,000 |  |  |  |  |  |  |
Nominal amount | € 2,580,000 |  |  |  | € 2,719 |  |  |  |  |  |  |  | $ 23,000,000 |  |  |
Maturity date |  |  |  |  |  |  | August 31, 2025 | August 31, 2025 |  |  |  |  |  |  |  |
Liquidity discount percentage |  |  |  |  | 10.00% | 10.00% | 10.00% | 10.00% |  |  |  |  |  |  |  |
Weighted average remaining contractual lifetime |  |  |  |  |  |  | 2 years 2 months 23 days | 2 years 2 months 23 days | 2 years 2 months 12 days | 2 years 2 months 12 days |  |  |  |  |  |
Increase in equity |  |  |  |  | € 1,249,000 |  | € 2,314,000 |  | € 729,000 |  |  |  |  |  |  |
Vested RSUs (in Shares) | shares |  |  |  |  |  |  | 21,005 | 21,005 |  |  |  |  |  |  |  |
Contractual life of the NQSOs outstanding |  |  |  |  | 7 years 7 months 2 days | 7 years 7 months 2 days | 8 years 3 months 18 days | 8 years 3 months 18 days | 8 years 3 months 18 days | 8 years 3 months 18 days |  |  |  |  |  |
Weighted average fair value of NQSO (in Dollars per share) | $ / shares |  |  |  |  |  | $ 4.91 |  | $ 4.24 |  |  |  |  |  |  |  |
Weighted average share price (in Dollars per share) | $ / shares |  |  |  |  |  | $ 11.37 |  | $ 11.21 |  |  |  |  |  |  |  |
Warrant liabilities include non-cash effective changes |  |  |  |  | € 57,539,000 |  | € 15,647,000 |  |  |  |  |  |  |  |  |
Impairment losses on financial assets |  |  |  |  | 55,000 |  | 58,000 |  | € (104,000) |  |  |  |  |  |  |
Cash |  |  |  |  | 6,987,000 |  | 22,858,000 |  |  |  |  |  |  |  |  |
Warrant liabilities |  |  |  |  | 11,259,000 |  | 119,581,000 |  |  |  |  |  |  |  |  |
Trade payables |  |  |  |  | € 20,865,000 |  | 35,171,000 |  |  |  |  |  |  |  |  |
Percentage of revenues |  |  |  |  | 82.00% | 82.00% |  |  |  |  |  |  |  |  |  |
Day One Loss [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred day one loss |  |  |  |  | € 12,392,000 |  | 12,392,000 |  |  |  |  |  |  |  |  |
Fair value of warrants |  |  |  |  |  |  | 16,669,000 |  |  |  |  |  |  |  |  |
Nominal amount |  |  |  |  |  |  | € 20,000,000 |  |  |  |  |  |  |  |  |
Warrant liabilities include non-cash effective changes |  |  |  |  | € 17,819,000 |  |  |  |  |  |  |  |  |  |  |
USD [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of revenues |  |  |  |  | 92.00% | 92.00% | 95.00% | 95.00% | 95.00% | 95.00% |  |  |  |  |  |
Depreciated percentage |  |  |  |  | 10.00% | 10.00% | 10.00% | 10.00% |  |  |  |  |  |  |  |
Onerous contracts provision [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Recognized provision onerous contract amount |  |  |  |  | € 25,000 |  | € 162,000 |  |  |  |  |  |  |  |  |
Cost of Goods Sold [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-based payments |  |  |  |  | 417,000 |  | 538,000 |  | € 147,000 |  |  |  |  |  |  |
Research and Development Expenses [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-based payments |  |  |  |  |  |  | 222,000 |  | 49,000 |  |  |  |  |  |  |
Selling, General and Administrative Expenses [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-based payments |  |  |  |  | 1,938,000 |  | 3,330,000 |  | 1,365,000 |  |  |  |  |  |  |
Shareholder Loans [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense |  |  |  |  | € 21,563,000 |  | € 16,106,000 |  | 2,784,000 |  |  |  |  |  |  |
Lender Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  |  |  |  |  | 100,000 |  |  |  |  |  | 100,000 |  |  |
Over-Allotment Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  |  |  | 937,486 |  |  |  |  |  | 937,486 |  |  |  |  |
Sponsor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  |  |  | 4,475,000 |  |  |  |  |  | 4,475,000 |  |  |  |  |
Top of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate tax rate |  |  |  |  | 15.00% | 15.00% |  |  |  |  |  |  |  |  |  |
Lease maturity runs |  |  |  |  | 4 years | 4 years |  |  |  |  |  |  |  |  |  |
Increase equity |  |  | € 6,741,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Trading days |  |  |  |  | 30 years | 30 years |  |  |  |  |  |  |  |  |  |
Average expected fluctuation |  |  |  |  | 10.00% | 10.00% | 10.00% | 10.00% |  |  |  |  |  |  |  |
Range of exercise prices (in Dollars per share) | $ / shares |  |  |  |  |  | $ 15.08 |  | $ 10.44 |  |  |  |  |  |  |  |
Average expected percentage |  |  |  |  | 10.00% | 10.00% | 10.00% | 10.00% |  |  |  |  |  |  |  |
Bottom of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate tax rate |  |  |  |  | 10.00% | 10.00% |  |  |  |  |  |  |  |  |  |
Lease maturity runs |  |  |  |  | 1 year | 1 year |  |  |  |  |  |  |  |  |  |
Trading days |  |  |  |  | 20 years | 20 years |  |  |  |  |  |  |  |  |  |
Average expected fluctuation |  |  |  |  | 0.00% | 0.00% | 0.00% | 0.00% |  |  |  |  |  |  |  |
Range of exercise prices (in Dollars per share) | $ / shares |  |  |  |  |  | $ 3.21 |  | $ 3.21 |  |  |  |  |  |  |  |
Average expected percentage |  |  |  |  | 0.00% | 0.00% | 0.00% | 0.00% |  |  |  |  |  |  |  |
Commercial and industrial [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue from contracts with customers |  |  |  |  | € 2,190,000 |  | € 1,677,000 |  | 14,186,000 |  |  |  |  |  |  |
Goods or services transferred over time [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue from contracts with customers |  |  |  |  | 0 |  |  |  | 1,602,000 |  |  |  |  |  |  |
ADSE [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Write-downs of inventories |  |  |  |  | € 13,198,000 |  | 689,000 |  | 8,093,000 |  |  |  |  |  |  |
Percentage of drawdown probability |  |  |  |  | 5.00% | 5.00% |  |  |  |  |  |  |  |  |  |
Other accrued |  |  |  |  | € 1,866 |  |  |  |  |  |  |  |  |  |  |
ADSE [Member] | Onerous contracts provision [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Recognized provision onerous contract amount |  |  |  |  | € 1,313,000 |  | € 3,719,000 |  | € 8,614,000 |  |  |  |  |  |  |
ADSE [Member] | Top of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  |  | 9.56% |  |  |  |  |  | 9.56% |  |  |  |  |
ADSE [Member] | Bottom of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  |  | 3.78% |  |  |  |  |  | 3.78% |  |  |  |  |
ADSE Holdco [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  |  |  | 12.68 |  |  |  |  |  | 12.68 |  |  |  |  |
Weighted average basic (in Shares) | shares |  |  |  |  | 56,394 | 56,394 | 51,224,000 | 51,224,000 | 48,919,000 | 48,919,000 |  |  |  |  |  |
Weighted average diluted (in Shares) | shares |  |  |  |  | 61,558,000 | 61,558,000 | 57,724,000 | 57,724,000 | 49,208,000 | 49,208,000 |  |  |  |  |  |
Increase in equity |  |  |  |  |  |  | € 1,775,000 |  |  |  |  |  |  |  | € 1,301,000 |
Payroll taxes decrease |  |  |  |  |  |  | 221,000 |  |  |  |  |  |  |  |  |
Net increase in equity |  |  |  |  |  |  | 2,094,000 |  | € 1,249,000 |  |  |  |  |  |  |
Charge box (CBX) [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Carrying amount |  |  |  |  | € 1,664,000 |  | 2,636,000 |  |  |  |  |  |  |  |  |
DC-CBX [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Carrying amount |  |  |  |  | 2,188,000 |  | 3,465,000 |  |  |  |  |  |  |  |  |
CPT [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Carrying amount |  |  |  |  | € 10,132,000 |  | € 12,159,000 |  |  |  |  |  |  |  |  |
Second shareholder loan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Constant maturity US treasury rates |  |  |  |  | 1 year 10 months 24 days | 1 year 10 months 24 days | 1 year 7 months 17 days | 1 year 7 months 17 days |  |  |  |  |  |  |  |
Other accrued |  |  |  |  |  |  | € 0 |  |  |  |  |  |  |  |  |
Warrants issued (in Shares) | shares |  |  |  |  |  |  | 2,500,001 |  |  |  |  |  | 2,500,001 |  |  |
Warrants exercise price (in Shares) | shares |  |  |  |  |  |  | 1,500,000 | 1,500,000 |  |  |  |  |  |  |  |
Warrants issued (in Dollars per share) | $ / shares |  |  |  |  |  |  |  | $ 6.2 |  |  |  |  |  |  |  |
Investor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Par value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 6 |  |
Shareholder Loans [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  |  | 10.00% |  |  |  |  |  | 10.00% |  |  |  |  |
Exercise of warrants |  |  |  |  |  |  | € 188,000 | $ 200,000 |  |  |  |  |  |  |  |
Fair value of warrants |  |  |  |  | € 35,377,000 |  | € 78,849,000 |  |  |  |  |  |  |  |  |
Warrants exercise price (in Shares) | shares |  |  |  |  |  |  | 6.2 | 6.2 |  |  |  |  |  |  |  |
Warrants shares issued (in Shares) | shares |  |  |  |  |  |  | 7,300,003 | 7,300,003 |  |  |  |  |  |  |  |
Loans and borrowings amount |  |  |  |  | 5,010,000 |  | € 13,333,000 |  |  |  |  |  |  |  |  |
Public Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  |  |  |  |  | 5,047,695 |  | 2,139,586 |  |  |  | 5,047,695 |  |  |
Warrant liabilities |  |  |  |  |  |  | € 40,731,000 |  | € 8,173,000 |  |  |  |  |  |  |
Private Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  |  |  |  |  | 2,773,255 |  |  |  |  |  | 2,773,255 |  |  |
Warrants exercise price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 3 |  |  |  |  |
EUSG [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,250,000
Nominal amount |  |  |  |  | € 21,957,000 |  | € 1,187,000 |  |  |  |  |  | $ 1,847,000 |  |  |
First Shareholder Loan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Constant maturity US treasury rates |  |  |  |  | 7 months 24 days | 7 months 24 days |  |  |  |  |  |  |  |  |  |
Warrants exercise price (in Shares) | shares |  |  |  |  |  |  | 1,716,667 | 1,716,667 |  |  |  |  |  |  |  |
Warrants issued (in Dollars per share) | $ / shares |  |  |  |  |  |  |  | $ 3 |  |  |  |  |  |  |  |
First Shareholder Loan [Member] | Top of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Constant maturity US treasury rates |  |  |  |  |  |  | 7 months 24 days | 7 months 24 days |  |  |  |  |  |  |  |
First Shareholder Loan [Member] | Bottom of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Constant maturity US treasury rates |  |  |  |  |  |  | 2024 years | 2024 years |  |  |  |  |  |  |  |
Second Shareholder Loan Plus [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Constant maturity US treasury rates |  |  |  |  |  |  | 1 year 7 months 17 days | 1 year 7 months 17 days |  |  |  |  |  |  |  |
Warrants issued (in Shares) | shares |  |  |  |  |  |  | 4,800,002 |  |  |  |  |  | 4,800,002 |  |  |
Warrants issued (in Dollars per share) | $ / shares |  |  |  |  |  |  |  | $ 6.2 |  |  |  |  |  |  |  |
Shareholder Loan Plus [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Nominal amount |  |  |  |  |  |  | € 1,280,000 |  |  |  |  |  |  |  |  |
NQSO [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase in equity |  |  |  |  |  |  | 1,775,000 |  | € 832,000 |  | $ 1,301 |  |  |  |  |
One Shareholder Loans [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Nominal amount |  |  |  |  |  |  | € 2,305,000 |  |  |  |  |  |  |  |  |
Germany [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues generated |  |  |  |  | 49.60% | 49.60% | 76.10% | 76.10% | 72.10% | 72.10% |  |  |  |  |  |
Ordinary shares [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  | 1,666,667 |  |  |  |  |  |  |  |  |  |  | 1,666,667 |  |
Par value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.0001 |  |
Issued share capital | $ |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 167,000 |  |
Ordinary price per share | $ |  |  |  |  |  |  |  |  |  |  | $ 433 |  |  |  |  |
Ordinary shares [member] | ADSE [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other accrued |  |  |  |  | € 0 |  |  |  |  |  |  |  |  |  |  |
Ordinary shares [member] | Second shareholder loan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other accrued |  |  |  |  |  |  | € 2,110,000 |  |  |  |  |  |  |  |  |
Restricted Stock Units (RSUs) [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholder loans |  |  |  |  | 1,249,000 |  | 2,314,000 |  | € 729,000 |  |  |  |  |  |  |
Capitalised development expenditure [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-based payments |  |  |  |  | 343,000 |  |  |  | 5,404,000 |  |  |  |  |  |  |
Customers [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash |  |  |  |  | 22,858,000 |  |  |  |  |  |  |  |  |  |  |
Customers [Member] | Over-Allotment Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholder loans |  |  |  |  |  |  | 10,286,000 |  |  |  |  |  |  |  |  |
Customers [Member] | Goods or services transferred at point in time [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue from contracts with customers |  |  |  |  | 5,831,000 |  | 37,225,000 |  | € 7,262,000 |  |  |  |  |  |  |
Customers [Member] | ADSE Holdco [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash |  |  |  |  | 6,987,000 |  |  |  |  |  |  |  |  |  |  |
Customers [Member] | Loans and Borrowings [Member] | Over-Allotment Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash |  |  |  |  | 6,987,000 |  |  |  |  |  |  |  |  |  |  |
Warrants [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant Liabilities |  |  |  |  | 40,567,000 |  |  |  |  |  |  |  |  |  |  |
Finance expense from remeasurement of warrant liabilities |  |  |  |  | € 8,724,000 |  |  |  |  |  |  |  |  |  |  |
Percentage of dividend yield |  |  |  |  | 0.00% | 0.00% |  |  |  |  |  |  |  |  |  |
Issued share capital |  |  |  |  |  |  | 128,000 |  |  |  |  |  | $ 138,000 |  |  |
Capital reserves |  |  |  |  |  |  | 15,835,000 |  |  |  |  |  |  |  |  |
Weighted average share price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 11.5 |  |  |  |  |
Warrant liabilities include non-cash effective changes |  |  |  |  | € 15,647,000 |  |  |  |  |  |  |  |  |  |  |
Warrant liabilities |  |  |  |  | € 54,808,000 |  |  |  |  |  |  |  |  |  |  |
Warrants [member] | ADSE Holdco [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued (in Shares) | shares |  |  | 1,339,285 |  |  |  |  |  |  |  |  |  |  | 1,339,285 |  |
Warrants shares issued (in Shares) | shares |  | 10,310 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  | 1827284 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
Six-Month Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Constant maturity US treasury rates |  |  |  |  | 4 years 3 months 29 days | 4 years 3 months 29 days |  |  |  |  |  |  |  |  |  |
Six-Month Warrants [Member] | Loans and Borrowings [Member] | Capitalised development expenditure [member] | EUSG [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure on individual items of the consolidated financial statements [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trade payables |  |  |  |  |  |  | € 2,275,000 |  |  |  |  |  |  |  |  |

X
- Definition The amount of additional amortization. + References No definition available. + Details
Name: | adse_AdditionalAmortizationAmount
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of aggregate fair value. + References No definition available. + Details
Name: | adse_AggregateFairValue
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of amortization of capitalized development costs. + References No definition available. + Details
Name: | adse_AmortizationOfCapitalizedDevelopmentCosts
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of average expected fluctuation. + References No definition available. + Details
Name: | adse_AverageExpectedFluctuation
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Average expected percentage. + References No definition available. + Details
Name: | adse_AverageExpectedPercentage
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represent the amount of carrying amount of asset. + References No definition available. + Details
Name: | adse_CarryingAmountOfAsset
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of cash deposit. + References No definition available. + Details
Name: | adse_CashDeposit
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Constant maturity treasury rates. + References No definition available. + Details
Name: | adse_ConstantMaturityTreasuryRates
Namespace Prefix: | adse_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Convertible note agreement description. + References No definition available. + Details
Name: | adse_ConvertibleNoteAgreementDescription
Namespace Prefix: | adse_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Convertible notes settled description. + References No definition available. + Details
Name: | adse_ConvertibleNotesSettledDescription
Namespace Prefix: | adse_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of corporate tax rate. + References No definition available. + Details
Name: | adse_CorporateTaxRate
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of deferred taxes. + References No definition available. + Details
Name: | adse_DeferredTaxesAmount
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of Dividend Yield. + References No definition available. + Details
Name: | adse_DividendYieldPercentage
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exceeds share price. + References No definition available. + Details
Name: | adse_ExceedsSharePrice
Namespace Prefix: | adse_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of exercise price. + References No definition available. + Details
Name: | adse_ExercisePrice
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair market value price per shares. + References No definition available. + Details
Name: | adse_FairMarketValuePricePerShares
Namespace Prefix: | adse_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share amount of fair value of per warrant. + References No definition available. + Details
Name: | adse_FairValueOfPublicWarrantsPerShare
Namespace Prefix: | adse_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of fair value of warrants. + References No definition available. + Details
Name: | adse_FairValueOfWarrants
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of fair value of warrants liability. + References No definition available. + Details
Name: | adse_FairValueOfWarrantsLiability
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Increase in capital reserves. + References No definition available. + Details
Name: | adse_IncreaseInCapitalReserves
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Increase in equity. + References No definition available. + Details
Name: | adse_IncreaseInEquity
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Lease maturity runs. + References No definition available. + Details
Name: | adse_LeaseMaturityRuns
Namespace Prefix: | adse_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Liquidity discount percentage. + References No definition available. + Details
Name: | adse_LiquidityDiscountPercentage
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maturity date. + References No definition available. + Details
Name: | adse_LoansAndBorrowingsMaturityDate
Namespace Prefix: | adse_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Net increase in equity. + References No definition available. + Details
Name: | adse_NetIncreaseInEquity
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents the number of warrants. + References No definition available. + Details
Name: | adse_NumberOfWarrants
Namespace Prefix: | adse_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of depreciated. + References No definition available. + Details
Name: | adse_PercentageOfDepreciated
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of drawdown probability. + References No definition available. + Details
Name: | adse_PercentageOfDrawdownProbability
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of revenues. + References No definition available. + Details
Name: | adse_PercentageOfRevenues
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Public warrants. + References No definition available. + Details
Name: | adse_PublicWarrants
Namespace Prefix: | adse_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Range of exercise prices. + References No definition available. + Details
Name: | adse_RangeOfExercisePricesNQSOs
Namespace Prefix: | adse_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of recognized deferred taxes . + References No definition available. + Details
Name: | adse_RecognizedDeferredTaxes
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Remaining contractual lifetime NQSOs. + References No definition available. + Details
Name: | adse_RemainingContractualLifetimeNQSOs
Namespace Prefix: | adse_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Remaining outstanding warrants. + References No definition available. + Details
Name: | adse_RemainingOutstandingWarrants
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Shareholder loans. + References No definition available. + Details
Name: | adse_ShareholderLoans
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Shares of warrants. + References No definition available. + Details
Name: | adse_SharesOfWarrants
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of solidarity surcharge thereon. + References No definition available. + Details
Name: | adse_SolidaritySurchargeThereonPercentage
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the trade tax. + References No definition available. + Details
Name: | adse_TaxRateEffectOfTradeTax
Namespace Prefix: | adse_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The term of warrants. + References No definition available. + Details
Name: | adse_TermOfWarrants
Namespace Prefix: | adse_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Trading days. + References No definition available. + Details
Name: | adse_TradingDays
Namespace Prefix: | adse_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of VAT receivable. + References No definition available. + Details
Name: | adse_VATReceivable
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represent the share vested exercised RSU repurchased. + References No definition available. + Details
Name: | adse_VestedExercisedRestrictedStockUnitRepurchased
Namespace Prefix: | adse_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision. + References No definition available. + Details
Name: | adse_WarrantExercisePriceDecrease1
Namespace Prefix: | adse_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. + References No definition available. + Details
Name: | adse_WarrantExercisePriceIncrease1
Namespace Prefix: | adse_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant liabilities. + References No definition available. + Details
Name: | adse_WarrantLiabilities
Namespace Prefix: | adse_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Warrants exercise price. + References No definition available. + Details
Name: | adse_WarrantsExercisePrice
Namespace Prefix: | adse_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants shares issued. + References No definition available. + Details
Name: | adse_WarrantsSharesIssued
Namespace Prefix: | adse_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average fair value of NQSO. + References No definition available. + Details
Name: | adse_WeightedAverageFairValueOfNQSO
Namespace Prefix: | adse_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average share price. + References No definition available. + Details
Name: | adse_WeightedAverageSharePrice
Namespace Prefix: | adse_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of assets representing income that has been earned but is not yet a receivable, other than contract assets. [Refer: Contract assets] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 78 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_AccruedIncomeOtherThanContractAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2025-01-01 -Paragraph 70 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_AdjustedWeightedAverageShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2025-01-01 -Paragraph 20 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_AdjustmentsForSharebasedPayments
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount by which a cash-generating unit's (group of units') recoverable amount exceeds its carrying amount. [Refer: Carrying amount [member]; Total for all cash-generating units [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2025-01-01 -Paragraph 134 -Subparagraph f -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_f_i&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2025-01-01 -Paragraph 135 -Subparagraph e -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_135_e_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_AmountByWhichUnitsRecoverableAmountExceedsItsCarryingAmount
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The tax expense (income) divided by the accounting profit. [Refer: Accounting profit] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2025-01-01 -Paragraph 81 -Subparagraph c -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 194 -Subparagraph c -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 194 -Subparagraph c -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_AverageEffectiveTaxRate
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of outstanding funds that the entity is obligated to repay. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_Borrowings
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The interest rate on borrowings. [Refer: Borrowings] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 7 -IssueDate 2025-01-01 -Paragraph 7 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_BorrowingsInterestRate
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition A component of equity representing the capital reserves. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_CapitalReserve
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2025-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph B13 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 169 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 169 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard -URIDate 2025-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 54 -Subparagraph i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_CashAndCashEquivalents
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The increase (decrease) in equity. [Refer: Equity] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ChangesInEquity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of current accrued income other than current contract assets. [Refer: Accrued income other than contract assets] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 78 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_CurrentAccruedIncomeOtherThanCurrentContractAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of current warrant liabilities. [Refer: Warrant liability] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_CurrentWarrantLiability
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The exercise price of outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ExercisePriceOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The exercise price of share options granted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ExercisePriceShareOptionsGranted2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_GovernmentGrants
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of impairment loss, impairment gain or reversal of impairment loss that is recognised in profit or loss in accordance with paragraph 5.5.8 of IFRS 9 and that arises from applying the impairment requirements in Section 5.5 of IFRS 9. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 82 -Subparagraph ba -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_ba&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The increase (decrease) in equity resulting from the exercise of warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of expense arising from interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2025-01-01 -Paragraph 28 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph B13 -Subparagraph f -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2025-01-01 -Paragraph 23 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_InterestExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 19 -IssueDate 2025-01-01 -Paragraph 141 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_b&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 207 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_207_b&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 207 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_207_b&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of interest recognised as a liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_InterestPayable
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 2 -IssueDate 2025-01-01 -Paragraph 36 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_e&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 164 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_d&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 164 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_d&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 98 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_a&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_InventoryWritedown2011
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The nominal value of capital issued. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B9 -Subparagraph f -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 78 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_IssuedCapital
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 78 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_IssuedCapitalOrdinaryShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of non-current warrant liabilities. [Refer: Warrant liability] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NoncurrentWarrantLiability
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The nominal or face amount of a financial instrument, used to calculate payments made on that instrument. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NotionalAmount
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of provision for onerous contracts. An onerous contract is a contract in which the unavoidable costs of meeting the obligation under the contract exceed the economic benefits expected to be received under it. [Refer: Other provisions] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 37 -IssueDate 2025-01-01 -Paragraph 66 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_OnerousContractsProvision
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The nominal value per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B10 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 160 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 79 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ParValuePerShare
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash outflow for share issue costs. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2025-01-01 -Paragraph 17 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_PaymentsForShareIssueCosts
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 8 -IssueDate 2025-01-01 -Paragraph 34 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_PercentageOfEntitysRevenue
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow from the exercise of share purchase warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2025-01-01 -Paragraph 17 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ProceedsFromExerciseOfWarrants
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 81B -Subparagraph a -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_ii&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ProfitLossAttributableToOwnersOfParent
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_RentalIncome
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_RestrictedCashAndCashEquivalents
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2025-01-01 -Paragraph 114 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2025-01-01 -Paragraph 113 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_113_a&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_RevenueFromContractsWithCustomers
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2025-01-01 -Paragraph 81 -Subparagraph c -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 194 -Subparagraph c -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 194 -Subparagraph c -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_TaxEffectOfTaxLosses
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of trade payables and other payables. [Refer: Trade payables; Other payables] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 54 -Subparagraph k -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_k&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_TradeAndOtherPayables
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 16 -IssueDate 2025-01-01 -Paragraph 73 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_c&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 200 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_c&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 200 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 19 -IssueDate 2025-01-01 -Paragraph 9 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_9&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WagesAndSalaries
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of warrant liabilities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WarrantLiability
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average share price. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageSharePrice2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2025-01-01 -Paragraph 70 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 133 -Subparagraph a -Clause v -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_133_a_v&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 98 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_a&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WritedownsReversalsOfInventories
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | ifrs-full_ClassesOfAssetsAxis=adse_DayOneLossMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CurrencyAxis=currency_USD
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfProvisionsAxis=ifrs-full_OnerousContractsProvisionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_CostOfSalesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=adse_ResearchAndDevelopmentExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfFinancialLiabilitiesAxis=adse_ShareholderLoansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfFinancialLiabilitiesAxis=adse_LenderWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | adse_SaleOfStockAxis=adse_OverAllotmentOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | adse_SaleOfStockAxis=adse_SponsorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=adse_CommercialAndIndustrialMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredOverTimeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_ADSEMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_ADSEHoldcoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_ChargeBoxCBXMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_DCCBXMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_CPTMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_SecondShareholderLoanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_InvestorrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_ShareholderLoansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_PublicWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_PrivateWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_EUSGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_FirstShareholderLoanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_SecondShareholderLoanPlusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_ShareholderLoanPlusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_NQSOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=adse_OneShareholderLoansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_DE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=adse_RestrictedStockUnitsRSUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfCustomersAxis=adse_CustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TimingOfTransferOfGoodsOrServicesAxis=ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=adse_LoansAndBorrowingsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfAntidilutiveInstrumentsAxis=adse_SixMonthWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |